MGTA News & Mentions

Popular stocks:

Mullen Automotive

TOP stocks:

Shares of other companies:

Merck & Co.

Nuvei

iQIYI

Dicerna Pharmaceuticals

Kirkland Lake Gold

Melco Resorts & Entertainment

Magenta Therapeutics (MGTA) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 8, 2023 (08:12)

Sector: Healthcare

The share price of Magenta Therapeutics, Inc. (MGTA) now

What analysts predict: $1

52-week High/Low: $2.24 / $0.32

50/200 Day Moving Average: $0.727 / $0.986

This figure corresponds to the Average Price over the previous 50/200 days. For Magenta Therapeutics stocks, the 50-day moving average is the resistance level today.

For Magenta Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Magenta Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Magenta Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Magenta Therapeutics share be worth in 2023 - 2027?

When should I take profit in Magenta Therapeutics stock? When should I record a loss on Magenta Therapeutics stock? What are analysts' forecasts for Magenta Therapeutics stock? What is the future of Magenta Therapeutics stock? We forecast Magenta Therapeutics stock performance using neural networks based on historical data on Magenta Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Magenta Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Magenta Therapeutics shares. This happens once a day.

Historical and forecast chart of Magenta Therapeutics stock

The chart below shows the historical price of Magenta Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Magenta Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Magenta Therapeutics daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Jun 10	0.70	0.70	0.71	2.45
Jun 11	0.70	0.69	0.71	2.85
Jun 12	0.70	0.69	0.71	2.51
Jun 13	0.71	0.70	0.72	3.13
Jun 14	0.71	0.70	0.73	3.50
Jun 15	0.71	0.70	0.72	3.44
Jun 16	0.71	0.69	0.72	3.38
Jun 17	0.71	0.70	0.72	2.57
Jun 18	0.70	0.69	0.71	3.69
Jun 19	0.68	0.67	0.69	2.65
Jun 20	0.68	0.68	0.69	1.57
Jun 21	0.70	0.68	0.70	3.47
Jun 22	0.71	0.69	0.72	3.53
Jun 23	0.72	0.70	0.73	3.93
Jun 24	0.74	0.73	0.75	2.33
Jun 25	0.75	0.75	0.76	1.42
Jun 26	0.77	0.77	0.78	2.12
Jun 27	0.78	0.77	0.79	2.61
Jun 28	0.76	0.75	0.77	3.27
Jun 29	0.74	0.73	0.75	2.82
Jun 30	0.74	0.73	0.75	2.04
Jul 01	0.74	0.73	0.75	3.28
Jul 02	0.74	0.72	0.75	3.30
Jul 03	0.74	0.72	0.75	3.78
Jul 04	0.76	0.75	0.77	1.98
Jul 05	0.77	0.76	0.78	2.50
Jul 06	0.76	0.74	0.77	2.87
Jul 07	0.77	0.76	0.78	2.24
Jul 08	0.75	0.73	0.76	4.11
Jul 09	0.75	0.74	0.76	2.28

Magenta Therapeutics Daily Price Targets

Magenta Therapeutics Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $0.70.
Negative dynamics for Magenta Therapeutics shares will prevail with possible volatility of 2.395%.
Pessimistic target level: 0.70
Optimistic target level: 0.71

Magenta Therapeutics Stock Forecast 06-11-2023.

Forecast target price for 06-11-2023: $0.70.
Negative dynamics for Magenta Therapeutics shares will prevail with possible volatility of 2.770%.
Pessimistic target level: 0.69
Optimistic target level: 0.71

Magenta Therapeutics Stock Forecast 06-12-2023.

Forecast target price for 06-12-2023: $0.70.
Positive dynamics for Magenta Therapeutics shares will prevail with possible volatility of 2.447%.
Pessimistic target level: 0.69
Optimistic target level: 0.71

Magenta Therapeutics Stock Forecast 06-13-2023.

Forecast target price for 06-13-2023: $0.71.
Positive dynamics for Magenta Therapeutics shares will prevail with possible volatility of 3.034%.
Pessimistic target level: 0.70
Optimistic target level: 0.72

Magenta Therapeutics Stock Forecast 06-14-2023.

Forecast target price for 06-14-2023: $0.71.
Positive dynamics for Magenta Therapeutics shares will prevail with possible volatility of 3.380%.
Pessimistic target level: 0.70
Optimistic target level: 0.73

Magenta Therapeutics Stock Forecast 06-15-2023.

Forecast target price for 06-15-2023: $0.71.
Negative dynamics for Magenta Therapeutics shares will prevail with possible volatility of 3.329%.
Pessimistic target level: 0.70
Optimistic target level: 0.72

MGTA (MGTA) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Jul.	0.67	0.62	0.69	9.97
Aug.	0.68	0.66	0.70	5.93
Sep.	0.71	0.63	0.76	16.42
Oct.	0.74	0.72	0.81	11.56
Nov.	0.77	0.73	0.80	8.87
Dec.	0.83	0.80	0.87	8.38

Full forecast for 2023

Magenta Therapeutics forecast for this year

Magenta Therapeutics Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $0.669455. Pessimistic: $0.62. Optimistic: $0.69

Magenta Therapeutics Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $0.679898. Pessimistic: $0.66. Optimistic: $0.70

Magenta Therapeutics Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $0.70553. Pessimistic: $0.63. Optimistic: $0.76

Magenta Therapeutics Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $0.744052. Pessimistic: $0.72. Optimistic: $0.81

Magenta Therapeutics Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $0.769201. Pessimistic: $0.73. Optimistic: $0.80

Magenta Therapeutics Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $0.826199. Pessimistic: $0.80. Optimistic: $0.87

Magenta Therapeutics (MGTA) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	0.84	0.78	0.87	9.83
Feb	0.81	0.75	0.84	10.41
Mar	0.85	0.83	0.94	11.64
Apr	0.83	0.76	0.88	13.49
May	0.79	0.74	0.84	12.01
Jun	0.73	0.68	0.78	12.17
Jul	0.69	0.65	0.75	13.83
Aug	0.71	0.67	0.78	14.13
Sep	0.80	0.75	0.84	10.87
Oct	0.75	0.72	0.82	11.40
Nov	0.84	0.77	0.88	11.78
Dec	0.89	0.84	0.97	13.26

Full forecast for 2024

Magenta Therapeutics (MGTA) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.94	0.91	1.02	10.61
Feb	0.96	0.93	1.04	11.37
Mar	0.96	0.91	1.05	12.60
Apr	0.91	0.84	0.98	13.73
May	0.96	0.91	0.99	7.81
Jun	0.91	0.86	0.98	12.36
Jul	1.00	0.92	1.07	14.16
Aug	1.09	1.05	1.17	10.35
Sep	1.23	1.13	1.30	13.40
Oct	1.23	1.19	1.32	9.74
Nov	1.24	1.17	1.30	10.17
Dec	1.26	1.15	1.31	11.57

Full forecast for 2025

Magenta Therapeutics (MGTA) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	1.16	1.10	1.19	8.08
Feb	1.18	1.14	1.26	9.35
Mar	1.31	1.25	1.39	9.70
Apr	1.47	1.43	1.53	6.63
May	1.59	1.43	1.75	18.18
Jun	1.60	1.44	1.71	16.05
Jul	1.75	1.67	1.94	13.78
Aug	1.85	1.67	1.97	15.57
Sep	1.77	1.64	1.87	12.16
Oct	1.77	1.69	1.90	11.12
Nov	1.79	1.73	1.92	9.96
Dec	1.78	1.66	1.92	13.61

Full forecast for 2026

Magenta Therapeutics (MGTA) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	1.89	1.77	1.96	9.88
Feb	1.79	1.70	1.97	13.72
Mar	2.01	1.80	2.18	17.16
Apr	2.16	1.96	2.36	16.78
May	2.11	2.04	2.26	10.06
Jun	2.12	1.91	2.34	18.39
Jul	2.33	2.27	2.46	7.76
Aug	2.58	2.35	2.78	15.45
Sep	2.77	2.59	3.02	14.32
Oct	2.50	2.24	2.58	12.98
Nov	2.53	2.36	2.64	10.80
Dec	2.55	2.38	2.78	14.28

Full forecast for 2027

Magenta Therapeutics information and performance

Magenta Therapeutics, Inc. is a clinical stage biotechnology company that develops new drugs for bone marrow transplantation. It offers a platform that focuses on critical areas of transplantation. The company was founded by David Scudden, Derrick Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner in June 2015 and is headquartered in Cambridge, Massachusetts.

Magenta Therapeutics Address

100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA, US

Market Capitalization: 43 364 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -69 360 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.56

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.399

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 60649000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Centene Corp. (CNC)

Athersys, Inc. (ATHX)

Sorrento Therapeutics, Inc. (SRNE)

Baxter International Inc. (BAX)

Kiniksa Pharmaceuticals, Ltd. (KNSA)

Change Healthcare Inc. (CHNG)

BiondVax Pharmaceuticals Ltd. (BVXV)

Haemonetics Corporation (HAE)

Aurinia Pharmaceuticals Inc. (AUPH)

Bavarian Nordic A/S (BVNRY)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/MGTA.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/MGTA.svg"> Magenta Therapeutics (MGTA) Stock Forecast for 2023 – 2026. Sell or Buy?